Misonix Announces New Distribution Agreement for The N...( FARMINGDALE N.Y. Nov. 5 /- Misoni...)

FARMINGDALE, N.Y., Nov. 5 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with privately-held Eclipse Medical BV, based in Rotterdam, The Netherlands, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne(R) Ultrasonic Wound Debrider. The agreement provides Eclipse Medical with the rights to sell in The Netherlands, and includes minimum purchase requirements.

Eclipse Medical, well known in The Netherlands marketplace as an aggressive competitor, has built a reputation as a distributor of state-of-the-art medical devices and capital equipment, with special emphasis on surgery and oncology.

The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt(TM) bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.

The SonicOne is an innovative, ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures. The So
'/>"/>